Drugs / Shengdi Dahuang Decoction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04200781 | Sep 2019 → Jun 2022 | hemorrhagic stroke | ShuGuang Hospital | Unknown | Met primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sheng-Di-Da-Huang Decoction | “Sheng-Di-Da-Huang Decoction was used as an effective hemostatic agent in ancient China.” PMID 30498516 ↗ Oct 2018 |
| Known as | SDD | “Per preliminary studies, Shengdi Dahuang Decoction (SDD) is potentially effective for acute intracerebral haemorrhage (ICH); however, its effectiveness has not been rigorously...” PMID 40752894 ↗ Apr 2026 |
| Modality | Traditional medicine (herbal / TCM) | “Treatment of acute intracerebral haemorrhage with a Chinese herbal formula” PMID 40752894 ↗ Apr 2026 |
| Route | Oral | “Patients were randomised 1:1 to receive either SDD granules (each sachet contained 15 g of raw Rehmannia glutinosa and 5 g of raw rhubarb) or placebo granules orally or via a...” PMID 40752894 ↗ Apr 2026 |
| Route | Other | “Patients were randomised 1:1 to receive either SDD granules (each sachet contained 15 g of raw Rehmannia glutinosa and 5 g of raw rhubarb) or placebo granules orally or via a...” PMID 40752894 ↗ Apr 2026 |